Loading clinical trials...
Loading clinical trials...
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Therapeutic Effect of Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
Conditions
Interventions
topical BPM31510 3.0% Cream
Locations
1
United States
University of Miami Department of Dermatology
Miami, Florida, United States
Start Date
August 10, 2016
Primary Completion Date
August 26, 2019
Completion Date
August 26, 2019
Last Updated
June 16, 2020
NCT06423573
NCT06330350
NCT05157958
NCT03526159
NCT07050810
NCT06330324
Lead Sponsor
Shasa Hu
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions